Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
Discover Cantor Fitzgerald's analysis on Innoviva, highlighting its unique royalty-based business model with GSK for asthma and COPD products.
This Kroger Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…
Unveiling 5 Analyst Insights On Editas Medicine
Throughout the last three months, 5 analysts have evaluated Editas Medicine (NASDAQ:EDIT), offering a diverse set of opinions…
Expert Outlook: Zuora Through The Eyes Of 8 Analysts
In the last three months, 8 analysts have published ratings on Zuora (NYSE:ZUO), offering a diverse range of…
The Analyst Verdict: Blackstone Mortgage Trust In The Eyes Of 8 Experts
Blackstone Mortgage Trust (NYSE:BXMT) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints…
Analyst Ratings For NiSource
Throughout the last three months, 4 analysts have evaluated NiSource (NYSE:NI), offering a diverse set of opinions from…
Pilgrim’s Pride Set For Growth As Analyst Projects Rising Demand For Chicken
Pilgrim's Pride benefits from high demand for chicken. Analyst gives Buy rating with $41 price target.
Economist React To May Retail Sales Data: ‘Consumer Spending Is Cooling In A Fairly Orderly Fashion’
US retail sales for May missed expectations, raising concerns about economic growth. Resilient consumer spending has been a key factor in the bull market.
Why This Kroger Analyst Is Turning Bullish
Kroger analyst upgrades rating from Market Perform to Outperform and raised price target due to stable gross margins and potential acquisition.
Evaluating Urban Outfitters: Insights From 9 Financial Analysts
9 analysts have expressed a variety of opinions on Urban Outfitters (NASDAQ:URBN) over the past quarter, offering a…